Journal Article Observational Study Ppublish 12 citations
PubMed: 34906382 DOI: 10.1053/j.jvca.2021.11.013
Bleeding Complications in Patients With Perioperative COVID-19 Infection Undergoing Cardiac Surgery: A Single-Center Matched Case-Control Study.
J Cardiothorac Vasc Anesth 36(7):1919-1926
Authors: Giovanni A Chiariello, Piergiorgio Bruno, Natalia Pavone, Maria Calabrese, Serena D'Avino, Francesco Ferraro, Marialisa Nesta, Piero Farina, Federico Cammertoni, Annalisa Pasquini, Rocco A Montone, Luca Montini, Massimo Massetti
Affiliations
- Cardiovascular Sciences Department, Agostino Gemelli Foundation Polyclinic IRCCS, Rome, Italy; Catholic University of The Sacred Heart, Rome, Italy.
- Cardiovascular Sciences Department, Agostino Gemelli Foundation Polyclinic IRCCS, Rome, Italy; Catholic University of The Sacred Heart, Rome, Italy.
- Cardiovascular Sciences Department, Agostino Gemelli Foundation Polyclinic IRCCS, Rome, Italy.
- Catholic University of The Sacred Heart, Rome, Italy; Department of Intensive Care Medicine and Anesthesiology, Agostino Gemelli Foundation Polyclinic IRCCS, Rome, Italy.
Abstract
OBJECTIVE
Previous studies reported a poor outcome in patients with coronavirus 2019 (COVID-19) undergoing cardiac surgery. Complications most frequently described were respiratory failure, renal failure, and thromboembolic events. In their recent experience, the authors observed a very high incidence of bleeding complications. The purpose of the study was to investigate a possible significant correlation between perioperative COVID-19 infection and hemorrhagic complications compared to non-COVID-19 patients.
DESIGN
Single-center, observational, retrospective, matched case-control (1:2) study involving patients who underwent open-heart cardiac surgery from February 2020 and March 2021 with positive perioperative diagnosis of COVID-19 infection, matched with patients without COVID-19 infection.
SETTING
Cardiac surgery unit and intensive care unit of a university tertiary center in a metropolitan area.
PARTICIPANTS
In the study period, 773 patients underwent cardiac surgery on cardiopulmonary bypass (CPB). Among them, 23 consecutive patients had perioperative diagnosis of COVID-19 infection (study group). These patients were compared with 46 corresponding controls (control group) that matched for age, sex, body mass index, and Society of Thoracic Surgeons score.
INTERVENTIONS
Open-heart cardiac surgery on CPB.
MEASUREMENTS AND MAIN RESULTS
In the study group, 2 patients (9%) died in the intensive care unit from severe respiratory failure, shock, and multiple organ failure. In the study group, patients showed a significantly higher incidence of bleeding complications (48% v 2%, p = 0.0001) and cases of surgical reexploration for bleeding (35% v 2%, p = 0.0001), a higher incidence of severe postoperative thrombocytopenia (39% v 6%, p = 0.0007), and a higher need of blood components transfusions (74% v 30%, p = 0.0006). Chest tubes blood loss and surgical hemostasis time were markedly prolonged (p = 0.02 and p = 0.003, respectively).
CONCLUSIONS
A worrisome increased risk of early and late bleeding complications in COVID-19 patients was observed, and it should be considered when assessing the operative risk. CPB-related inflammatory reaction could exacerbate the deleterious effect of COVID-19 on the coagulation system and likely deviate it toward a hemorrhagic pattern.
MeSH
Incidence, Infections, Thoracic Surgery, Cardiac Surgical Procedures, Anesthesia, Diagnosis, Risk, Heart, Hemorrhage, Intensive Care Units, Cardiopulmonary Bypass, Case-Control Studies, Vascular Surgical Procedures, Blood, Coronavirus, Covid-19
Cited by
- Outcomes of Patients Undergoing Major Surgery for Cancer with COVID-19 in the Postoperative Period. Indian J Surg Oncol, 2024
- Coagulation and Transfusion Updates From 2021. J Cardiothorac Vasc Anesth, 2022
- Association of major postoperative wound and anastomotic complications in thoracic surgery with COVID-19 infection. Surg Open Sci, 2022
- The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer. In Vivo, 2022